Загрузка...
Efficacy and safety of exenatide once‐weekly vs exenatide twice‐daily in Asian patients with type 2 diabetes mellitus
AIMS/INTRODUCTION: To compare safety and efficacy of the extended‐release formulation exenatide once weekly (EQW) vs exenatide twice daily (EBID) for 26 weeks in type 2 diabetes patients from China, India, Japan, South Korea and Taiwan. MATERIALS AND METHODS: A randomized, comparator‐controlled, ope...
Сохранить в:
| Главные авторы: | , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Wiley-Blackwell
2013
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4019288/ https://ncbi.nlm.nih.gov/pubmed/24843631 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.2040-1124.2012.00238.x |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|